Pharmacists in San Jacinto, California


29 Pharmacists found in San Jacinto
female pharmacist

Nadia Nguyen


Pharmacist
1811 S San Jacinto Ave, San Jacinto, CA 92583
951-487-6185    

female pharmacist

Dr. Oluwafolake Omotosho, PHARMD


Pharmacist
2261 W Esplanade Ave, San Jacinto, CA 92582
951-487-2383    

female pharmacist

Dr. Pamela Hung, PHARMD


Pharmacist
1605 S San Jacinto Ave, San Jacinto, CA 92583
951-654-4734    



male pharmacist

Dr. Peter Dinh Nguyen, PHARM.D


Pharmacist
1180 N State St, San Jacinto, CA 92583
951-487-1915     951-487-1749

male pharmacist

Peter Nguyen


Pharmacist
1181 N State St, San Jacinto, CA 92583
951-487-3810     951-654-6283

male pharmacist

Ribhi A Hamad, RPH 41407


Pharmacist
1181 N Sate St, San Jacinto, CA 92583
951-487-3810    

male pharmacist

Ron W Cloyd, R.PH


Pharmacist
1271 N State St, San Jacinto, CA 92583
951-654-4221     951-654-4466

male pharmacist

Dr. Sayyed Dhiaaddin Saadi, PHD


Pharmacist
1180 N State St, San Jacinto, CA 92583
951-487-1915    

male pharmacist

Mr. Sean Yu, PHARMD


Pharmacist
2261 W. Esplanade Ave, San Jacinto, CA 92582
951-487-2383    

male pharmacist

Shiheng Hsu


Pharmacist
1861 S San Jacinto Ave, San Jacinto, CA 92583
951-487-8409    

female pharmacist

Thuy Nguyen


Pharmacist
102 S Sanderson Ave, San Jacinto, CA 92582
951-487-9185    

female pharmacist

Vykhanh Tarr, PHARMD


Pharmacist
1477 S San Jacinto Ave, San Jacinto, CA 92583
951-654-2791    

female pharmacist

Miss Yea-shin Yeh, PHARMACIST


Pharmacist
1605 S San Jacinto Ave, San Jacinto, CA 92583
951-654-4734    


Type of Pharmacists:
Psychiatric Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in optimizing care of patients with psychiatric illness by assessing and monitoring patients, recognizing drug-induced problems, and recommending appropriate treatment plans.
Oncology Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in developing, recommending, implementing, monitoring, and modifying pharmacotherapeutic plans to optimize outcomes in patients with malignant diseases.